Immature platelet fraction in patients diagnosed with COVID-19
Indian Journal of Pathology and Microbiology · 2025-04 · 68 (2) · 349-353
DOI: 10.4103/ijpm.ijpm_365_24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indian Journal of Pathology and Microbiology, online erschienen am 02.09.2024. Verfasst von Neha Parashar und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pathology, Lok Nayak Hospital, New Delhi, India. Hauptthemen laut MEDLINE: COVID-19, Thrombocytopenia, Blood Platelets. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
Background
The recent pandemic caused by the newly identified virus, SARS-Cov-2 is associated with thromboembolic events. Patients infected with COVID-19 have been found to have thrombocytopenia. A decrease in platelet count may be caused by increased destruction and consumption of platelets or by decreased production of platelets in the bone marrow. Immature platelet fraction (IPF) is a new platelet parameter that is an indicator for peripheral destruction and consumption of platelets.
Objectives
To assess the immature platelet fraction (IPF) in patients infected with COVID-19. Materials and Methods: The present study is a retrospective study where secondary data obtained from previous laboratory records of COVID-positive patients admitted at a tertiary care hospital in Delhi from 4 January to 4 February 2022 was analyzed. Sixty-eight COVID-positive patients were included. Platelet parameters included from the automated hematology analyzer Mindray were platelet count, mean platelet volume (MPV), immature platelet fraction (IPF), and platelet large cell ratio (P-LCR). Data was analyzed using SPSS Version 25. A P value less than 0.05 was considered statistically significant.
Results
In the present study mild thrombocytopenia was noted in 40% of the patients infected with COVID-19 admitted to the hospital. The median platelet count in these patients was found to be 91,000/mm 3 (64,000–1,31,000). Low platelet count was associated with a significantly higher IPF, MPV, PDW, P-LCR, and a significantly lower PCT as compared to patients infected with COVID-19 with normal platelet count. There was a significant increase in IPF with a decrease in platelet count ( P value < 0.05). A significant increase in IPF was noted with an increase in MPV and P-LCR ( P value < 0.05). Interpretation and Conclusion: The present study suggests that thrombocytopenia in patients infected with COVID-19 may probably be due to peripheral destruction and consumption of platelets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Pathology, Lok Nayak Hospital, New Delhi, India.
- Department of Community Medicine, Maulana Azad Medical College, New Delhi, India.
- Department of Pathology, Sushruta Trauma Centre Associated with Lok Nayak Hospital, New Delhi, India.
- Department of Medicine, Maulana Azad Medical College and Lok Nayak Hospital, New Delhi, India.
Zitieren
APA
Parashar, N., Gupta, R. J., Gupta, D., Siroha, A., Garg, S., & Kumar, S. (2025). Immature platelet fraction in patients diagnosed with COVID-19. Indian Journal of Pathology and Microbiology, 68(2), 349-353. https://doi.org/10.4103/ijpm.ijpm_365_24
Vancouver
Parashar N, Gupta RJ, Gupta D, Siroha A, Garg S, Kumar S. Immature platelet fraction in patients diagnosed with COVID-19. Indian Journal of Pathology and Microbiology. 2025;68(2):349-353. doi:10.4103/ijpm.ijpm_365_24
BibTeX
@article{Parashar2025,
author = {Parashar, Neha and Gupta, Rashmi J and Gupta, Divya and Siroha, Alka and Garg, Sandeep and Kumar, Suresh},
title = {Immature platelet fraction in patients diagnosed with COVID-19},
journal = {Indian Journal of Pathology and Microbiology},
year = {2025},
volume = {68},
number = {2},
pages = {349--353},
doi = {10.4103/ijpm.ijpm_365_24}
}
EUVIMED